Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    10 October 2023

    Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer

    London, UK - Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, announces that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO). ...

    10 October 2023

    Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

    Cambridge, UK - Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof o...

    6 October 2023

    Seaweed to food - protein research company BravelyCultured moves into The Epicentre, Haverhill

    BraveleyCultured, a bio-tech company that is looking to use marine micro-organisms mainly in the foodtech sector, is the latest to take laboratory desk space at The EpiCentre in Haverhill. ...

    5 October 2023

    Bio-Rad extends range of anti-idiotypic antibodies for use in preclinical and clinical drug development

    Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring. ...

    4 October 2023

    FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Maja Pedersen as Chief Quality Officer

    Hillerød, Denmark – FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen announces a new strategic leadership appointment to support the company through its next growth phase. ...

    6 October 2023

    FirstStage - a VR creative toolkit

    The FirstStage VR toolkit is a collaborative virtual production tool that is applicable across multiple industries. ...

    4 October 2023

    Group B Streptococcus vaccines - not just for the baby

    This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global demand assessment for Group B Streptococcus (GBS) vaccines. ...

    9 October 2023

    Undiagnosed breathing conditions could cause winter NHS crisis

    electronRx writes...

    4 October 2023

    electronRx shares views on lack of health research hindering public support for clean air schemes

    The recent extension of the London ULEZ zone has been contentious with much public backlash to its introduction earlier this year. The public see this as a direct impact to them as opposed to understanding the benefits to their ongoing health and wellbeing. Experts say Cle...

    4 October 2023

    Evonetix places first DNA synthesis development platform at Imperial College London

    External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 165
    • Page 166
    • Current page 167
    • Page 168
    • Page 169
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS